An article about Norway's program for stratified cancer treatment was published in the prestige science journal Nature on February 2nd 2012. It was stated that: “Norway is set to become the first country to incorporate genome sequencing into its national health-care system."

Professor Ola Myklebost from the Institute for Cancer Research at Oslo University Hospital together with James Peach, director of stratified medicine at Cancer Research UK were both interviewed. Mr. Peach pointed out in the article that: “The Norwegians are quite lucky in that they’re planning their initiative later than ours” when he was interviewed about the national program for stratified cancer treatment in Norway.

Massive media attention
The article in Nature has generated a massive media interest in Norway. You may read an interview with Ola Myklebost with NRK here and watch an interview with Ola Myklebost and Ragnhild Lothe with NRK here (scroll to 7:48).

Presented in Norway
Both the Norwegian project and the one in UK were presented for Norwegian clinicians, hematologist and industry at Cancer Crosslinks, January 12th 2012. Cancer Crosslinks is a national meeting place in Norway in where the latest trends in oncology research and clinical development are discussed.

Read the article in Nature here

Read more about Cancer Crosslinks 2012 here